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Background: Non-communicable diseases (NCDs) kill 40 million people each year. The management of chronic
respiratory NCDs such as chronic obstructive pulmonary disease (COPD) is particularly critical in Italy, where they are
widespread and represent a heavy burden on healthcare resources. It is thus important to redefine the role and
responsibility of respiratory specialists and their scientific societies, together with that of the whole healthcare
system, in order to create a sustainable management of COPD, which could become a model for other chronic
respiratory conditions.
Methods: These issues were divided into four main topics (Training, Organization, Responsibilities, and
Sustainability) and discussed at a Consensus Conference promoted by the Research Center of the Italian Respiratory
Society held in Rome, Italy, 3–4 November 2016.
Results and conclusions: Regarding training, important inadequacies emerged regarding specialist training - both
the duration of practical training courses and teaching about chronic diseases like COPD. A better integration
between university and teaching hospitals would improve the quality of specialization. A better organizational
integration between hospital and specialists/general practitioners (GPs) in the local community is essential to
improve the diagnostic and therapeutic pathways for chronic respiratory patients. Improving the care pathways is
the joint responsibility of respiratory specialists, GPs, patients and their caregivers, and the healthcare system. The
sustainability of the entire system depends on a better organization of the diagnostic-therapeutic pathways, in
which also other stakeholders such as pharmacists and pharmaceutical companies can play an important role.
Keywords: Chronic obstructive pulmonary disease, Organization, Responsibilities, Sustainability, Training* Correspondence: snardini.pneumologo@gmail.com
The 4th Consensus Conference in Respiratory Medicine was held in Rome,
November 3–4, 2016.
1Italian Respiratory Society - Research Center, Milan, Italy
Full list of author information is available at the end of the article
© The Author(s). 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Nardini et al. Multidisciplinary Respiratory Medicine  (2017) 12:28 Page 2 of 9Background
According to WHO [1], non-communicable diseases
(NCDs) “kill 40 million people each year”. Globally, this
figure represents about 70% of all deaths. Among NCDs,
after cardiovascular diseases and cancer, respiratory dis-
eases rank as the 3rd cause of death, just before diabetes.
Overall, more than 80% of all premature NCD deaths
are due to these four diseases. In its action plan [2]
WHO recommends “to strengthen and orient health sys-
tems to address the prevention and control of NCDs”
and fosters a comprehensive approach to cope with
them, which includes “detecting, screening and treating
these diseases, and providing access to palliative care for
people in need”.
The management of chronic diseases is particularly
critical in the respiratory field. In Italy, these diseases are
very widespread (respiratory diseases including lung can-
cer constitute the 2nd cause of mortality) and account
for high healthcare resources consumption. Neverthe-
less, throughout Italy the number of hospital respiratory
units and specialist beds continues to decline (the num-
ber had already been reduced) without a consistent and
organized alternative provided outside the hospital, while
each year the number of respiratory specialists that
graduate from universities is inadequate to meet the
needs of the respiratory specialty.
In response to this situation, a redefinition of the con-
tents of Respiratory Medicine is necessary, as well as of
the role and responsibility of respiratory specialists and
their scientific societies, recognizing the needs, and jointly
sharing the organization of a new model of management
of respiratory diseases for clinical practice that is sustain-
able by the whole system. The challenge is to render the
care process effective and sustainable through the cooper-
ation of all stakeholders, by: i) improving the prescriptive
appropriateness and efficacy of general practitioners
(GPs); ii) defining integrated care pathways involving GPs,
respiratory specialists and the hospital; iii) developing new
modalities of drug delivery; iv) promoting greater partici-
pation of patients and their care givers (in Italy, the model
to follow is that of diabetes [3]) also with the use of tele-
medicine [4]; and v) involving the pharmaceutical system
in the management of the whole process.
Chronic obstructive pulmonary disease (COPD) may
be used as a model to discuss these issues. The preva-
lence of COPD is not known with certainty in Italy, but
it is estimated to vary from 4.03 to 5.55% in males and
2.60 to 4.45% in females [5]. However, the results of a
more recent survey in the general population, limited to
North-Eastern Italy and based on a questionnaire and
spirometry, revealed a global COPD prevalence much
higher, ranging from 6.8 to 11.7% according to the
screening method [6]. In any case, the disease is very
widespread and has a heavy impact on the nationalhealth system (NHS). Indeed, several care models
already exist, some of which have been adopted at local
level, at least in a pilot phase.
To seek and propose solutions to the current challenge
of chronic respiratory diseases in Italy, in particular
COPD, the Research Center of the Italian Respiratory
Society (IRS) organized the 4th Consensus Conference in
Respiratory Medicine, held in Rome, November 3–4,
2016, inviting the audience (all invited stakeholders) to
discuss the issues and arrive at agreement on how to
create a sustainable management of COPD, which could
become a model for other chronic respiratory condi-
tions. This paper is a report of what was discussed and
agreed during the Consensus Conference.
Methods
The Research Center of the Italian Respiratory Society
(IRS) adopted the method of Consensus Conference,
now in its Fourth Edition, in order to seek and propose
solutions to the four topics:
1. Training: basic educational curriculum and
continuing medication education (CME); the role of
Institutions and Scientific Societies.
2. Organization: specific roles of the hospital, GPs,
local community, and pharmaceutical system in a
network of respiratory medicine; to define the role
of policy makers, health professionals, and users in
building up a network.
3. Responsibilities: the reciprocal responsibility of
respiratory specialists, GPs, policy makers, patients
and their caregivers.
4. Sustainability: epidemiological burden of respiratory
diseases: primary prevention, early diagnosis,
therapy, and rehabilitation. Sustainability of
respiratory specialty in the NHS; definition of
essential care levels and diagnostic-therapeutic
pathways.
The Consensus Conference (CC) was organized and
carried out according to a methodology recommended by
the National Guidelines System (http://www.snlg-iss.it/
cms/files/manuale_metodologico_consensus.pdf-). A CC
is considered the most adequate tool for formulating rec-
ommendations on controversial topics that cannot be
evaluated based on reviews and quantitative studies due to
the many experiences that need to be confronted. How-
ever, usually the CC deals with technical or clinical aspects
and the audience involved is composed of specialists of
the same specialty. This CC dealing with organizational as
well as political aspects required participation of represen-
tatives from different disciplines and backgrounds.
Although some difficulties were experienced, after lively
discussion a number of issues were formulated and then
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reviewed and validated by the members of an independent
Jury. Due to the nature of the topics treated, the expected
result may be defined as the best possible agreement
among the individual positions and experiences of partici-
pants, the group of experts and the Jury.
In detail, the players involved and their specific
tasks were:
– The Promoting Committee (PC): included members
of the Research Center of the Italian Respiratory
Society, A.GE.NAS (National Agency for Health
Assistance), Federanziani (Federation of Elderly),
FIMMG (Italian Federation of General
Practitioners), Health Ministry, SIMM (Italian
Society of Medical Managers), and Federfarma
(Federation of Pharmaceutical Industries). The PC
promoted the CC, appointed the members of the
Technical and Scientific Committee and those of the
Jury, and prepared specific questions on each of the
four selected topics.
– The Technical and Scientific Committee (TSC):
composed of individuals of recognized experience in
the field, discussed the questions and selected the
teams charged with preparing the material for
discussion during the conference.
– The Jury: composed of 12 members selected by the
PC and TSC representing physicians
(multidisciplinary context), patients and their
associations. The Jury read the reports, attended the
CC and participated in the discussion, recorded
relevant new contributions to the presentations
(including disagreement), and wrote up the
consensus document.
– The Assembly: included all the people invited and
who attended the CC.Results and discussion
The results for the four topics are reported below. Each
topic was introduced by a brief review of the state of the
art, according to recommendations of guidelines and
organizational documents, followed by a comparison
with the real situation existing now. The possible devia-
tions and critical issues were outlined and some
proposals were formulated for improving the manage-
ment of COPD and other chronic respiratory diseases.
At the end of the discussion on each topic, the assembly
approved some statements, for subsequent examination
by the Jury before definitive validation.Training
The questions preliminarily put to the Working Group
in charge of developing this topic were:a. Does the University adequately educate the
specialist? If not, what are the main gaps in
formation?
Based on the report and lively discussion, the points
that emerged and were approved by the Assembly were:
– University education for undergraduate medical
students in Italy is substantially adequate concerning
the rudiments of respiratory medicine.
– Fundamental notions of respiratory medicine are,
however, not always taught by respiratory specialists
but by others (e.g. by internists) with a resulting lower
characterization and in-depth analysis of specialist
notions, especially those relative to respiratory
physiology, that are indispensable for a basic
education.
– There are important inadequacies in the
organization of students’ practical training, both in
terms of the duration (which is too short and
dispersed - i.e. few hours, differently scheduled in
different universities – compared to the ideal
duration of 1 month of theoretical and practical
teaching linked to cardiology and thoracic surgery),
and the training given on the most frequent chronic
diseases (asthma and above all COPD, and
cardiovascular comorbidities which frequently occur
in these patients). Also, a strong need was stressed
for organized teaching networks which include
teaching hospitals (see below).
b. Do non-academic hospitals have a role in the
education of the specialist? If yes, what role and
the timing?
– The proposal made by academic respiratory
specialists was confirmed on the need to set up
teaching networks in which training is integrated
with the so-called “teaching hospitals”, i.e. hospitals
characterized by a high level of specialization, with
expertise in other specialist or ultra-specialist areas
associated to mainline respiratory medicine.
– This integration should be through practical training
courses (e.g. mannequin maneuvers, tutor-assisted
trials of mechanical ventilation, intubation, endos-
copy etc.) that are certified and validated, carried
out over the entire duration of specialization and
with an adequate number organized each year.
– A similar training integration should be set up for
chronic respiratory diseases like asthma and COPD
(which are so widespread and have high rates of
morbidity, mortality, and social costs), covering not
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clinical and rehabilitative management outside hospital.
– At present, one of the most important issues in
COPD management concerns the role of GPs,
whose task is early diagnosis by means of
anamnestic and clinical evaluation and spirometry.
In fact, basic spirometry (first level investigation)
could be carried out by GPs in their setting after
adequate training, but this issue is still a matter of
discussion and disagreement, while the specialist’s
role would be a more in-depth patient assessment
with second level examinations.
– Another critical point is related to the community
health organization, still highly deficient as regards
patient management and rehabilitation, which is
important for health-related quality of life and long-
term outcome of chronic patients.
c. Besides the present model of Continuing
Medical Education (CME), would another system
based on certification both of the specialist and
structure, with internal and external audit, be
desirable? If yes, what and how often?
The HERMES Project (Harmonized Education in
Respiratory Medicine for European Specialists)
[7] could be adopted in Italy to educate
respiratory specialists so that they are able to
practice also in Europe or in other countries.
The Assembly unanimously expressed its
approval of this proposal, also hoping for an
even greater inclusion of Italian specialists in
high-level educational projects like HERMES
under the aegis of the European Respiratory
Society. However, this is not the only model and
scientific societies could play an important role
in delivering CME and carrying out audits. There
is need for periodic evaluation of structures,
specialists, and even GPs. HERMES is a
European reference model already existing, but
besides this the assembly pointed out the need
for frequent internal and external audit at
different levels in order to make our future
organization more efficient and adequate.Organization
Questions relative to the second topic discussed were:
a) Not all Italian regions include in their health
system the community respiratory specialist; is
there any role for this type of specialist?
After a lively discussion on this issue, the following
statements were formulated:1. The role of the outpatient specialist should be to
cooperate with GPs in primary care settings for the
diagnosis of diseases, promotion of primary and
secondary prevention, and care of patients
discharged from hospital to integrated home-care,
and to be in charge of the respiratory rehabilitation
program and end of life care.
2. To the hospital and community respiratory
specialists are reserved: second and third level
investigations for proper diagnosis and staging,
clinical-therapeutic management of the acute phase,
including in-hospital sub-intensive care, and the
respiratory rehabilitation carried out inside or
outside hospitals.
3. In Italy, the community respiratory specialist is
not defined as a standard and there are still
many health districts without such a physician.
This kind of specialist can act as an intermediate
reference figure between the hospital specialists
and GPs. This figure would be of particular
importance to take care, together with the GP, of
those cases that can be treated in the
community, so lowering the present heavy
burden of hospital admissions.
4. It is believed that the presence of this type of
specialist, included in a well-organized network of
primary care, where the objectives are agreed and
shared by all involved, could lead to a partial but
significant decrease in hospital admissions.
b. The Italian (autonomous respiratory unit) and
the United Kingdom (a multidisciplinary
department with one senior and one junior
consultant plus physicians in training) models of
hospital specialist system: what are the points of
strength and weakness?
The conclusions of the discussion on this point were:
Apparently, there is no difference because both
systems seem to meet the new health needs. Both in
UK and in Italy (in both countries the public health
system is going through an economic crisis) the
organization of hospital structures does not seem
coherent with the changes that have determined vari-
ous new needs and demands on public health. The lon-
ger life expectancy and the change toward healthier
lifestyles have led to an increased prevalence of chronic
conditions, whose diagnostic and therapeutic manage-
ment is totally different from that of acute illnesses.
Presently chronic diseases represent 80% of all health
requests [8], thus it is crucial to foster an improved
quality of care in respiratory hospital departments,
whether complex or simple units, for acute patients
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setting. For this reason, the number of beds is not
important but rather how they are utilized (i.e. only for
acute patients requiring highly specialized care and for
the shortest time possible, so creating a more efficient
turnover). The assembly pointed out the need for some
beds of intensive and/or semi-intensive care in each
respiratory department (2–4 beds each 200,000
inhabitants). It is also important from a therapeutic
point of view to organize community-based continuity
of care and make respiratory post-intensive rehabilita-
tion available in structures in the local community or at
home. The assembly concluded that the Italian system
better meets the health needs of the population than
the UK system and seems more suitable as a model of
specialized hospital respiratory care in future years, but
it also recognized that the national health system,
mainly to reduce costs, is massively reducing the num-
ber of respiratory units in Italy.
b. Some Italian regions have produced
diagnostic-therapeutic pathways (DTPs) for
COPD: what are the organizational similarities
and differences?
After an intense exchange of views and experiences
by participants, an agreement was reached on these
issues:
– Regarding regional and local diagnostic-
therapeutic pathways, great differences emerged,
especially concerning COPD, where the present
situation varies from regions where all or nearly
all local health systems have a specific DTP to
other regions where DTPs are totally missing, or
alternatively different denominations are used to
identify the same organizational pathway. In
some cases, the National Guidelines [9, 10] are
not even mentioned.
– Not all give the necessary importance to primary
prevention (lifestyle modification, etc.), smoking
cessation treatment, or early diagnosis.
– The patient’s role is almost never indicated, while
exclusive importance is assigned to the role of
physicians and other health workers who take care
of patients.
– The organization in the local community is different
not only because the structure is different but
mainly because at the moment much is based on the
personal initiative of specialists, as a precise
structural organization for national and local
management is still lacking.
– The same competence is assigned to different figures
(e.g. in some settings, performance of the firstspirometry examination is the responsibility of the
respiratory specialist, in others of the GP).
– In many settings some professional figures (e.g.
nurse and physiotherapist) are missing that provide
an appropriate and fundamental support for the
specialist during the diagnostic-therapeutic-
rehabilitative process of respiratory patients.
– Frequently, a rehabilitative pathway is not present or
envisaged.
From these evaluations, it stems that not always is the
community able to take care of patients who are in a
post-acute phase, and to manage the whole pathway of
chronic respiratory disease at home. This seems to be
the main reason why hospital admissions for COPD are
so numerous.
Rehabilitative structures, post-acute departments,
associations of GPs, domiciliary nurse assistance, active
patient associations, and a suitable family environment
are all lacking, and, most important, there is no
definition of network fundamentals (agreed and shared
roles and interventions of the health personnel who are
in touch with the patients). The results reported at
point “a” and “b” of this session are an attempt to
respond to these inadequacies and could be imple-
mented according to the whole COPD pathway de-
scribed in a recent multidisciplinary paper [11].
Responsibilities
In this session the questions to be discussed were:
a. What is the responsibility of the respiratory
specialist for the management of chronic
respiratory disease?
b. What is the responsibility of the GP for the
management of chronic respiratory disease?
c. What is the responsibility of patients and their
caregivers for the management of chronic
respiratory disease?
The Assembly agreed that the adherence to therapy
and the integration of care are indispensable to reduce
the organizational deficiencies underlying inappropriate
care practices. These can be measured everywhere in
our country by the rate of unsuitable admissions to
emergency departments (white codes) of patients
affected with chronic diseases. Obviously, the emergency
department, although providing an immediate practical
solution, does not resolve the problem of continuity of
care, but rather renders it more complicated. In fact,
while it copes with a health need (true or supposed) at
that moment, it further fragments the care pathway.
Conversely, to obtain the best management of COPD it
is necessary to make GPs more responsible. The solution
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tween primary care and hospital, set up home and com-
munity care structures, and formulate a new definition
of the hospital’s task as acute care only. The Assembly
recognized that it is hard, if not impossible, to put this
into practice if the NHS does not become strongly aware
of these issues. In fact, it must plan and fund the activity
of prevention and the integration of health services. Spe-
cifically, the NHS’s task is:
1. To organize the “respiratory care network” i.e. the
coordination system between hospital and local
territory, promote the setting up of DTPs (possibly
similar to a National model which - at least for
COPD - already exists [10]) suited to the reality and
sustainable, and assess their feasibility and efficiency
by means of audit and periodic reviews.
2. To organize and fund effective communication
campaigns in order to inform people about chronic
respiratory diseases, their characteristics and modes
of prevention, early diagnosis and treatment
adherence.
3. To promote and fund the computerization
(according to a unique National model and
consequently utilizable by any regional systems) of
the health system making it possible to share in real-
time, between interested (and authorized) subjects,
all the health information related to an individual.
Unfortunately, the present computerized
information system is not uniformly established
throughout the country, and there are frequent
differences both among regions and among health
districts of the same region. As well, the programs
are not always able to dialogue each other or not
suitable for a health environment and related issues.
4. To formulate a new definition of the timing of
specialist consultations and services which would
take into account the real time consumption of
these services including not only the usual medical
activities (history, diagnosis and prescriptions) but
also education about the disease (nature and
evolution of the disease), counseling and training in
device use. This action may parallel that at point 3.
5. (partly alternative to the preceding point) To review
tasks and competences, e.g. some activities presently
carried out by respiratory specialists (e.g. filling in a
form, education about the disease) should instead be
carried out by administrative, health, or voluntary
personnel, adequately trained. Hence it is necessary
to promote a coherent education of all health
workers to reach the above specific objectives.
In this context, the health professionals (both respira-
tory specialists and GPs) have the responsibility for:1. Adherence (as per their specific competence) to the
agreed diagnostic-therapeutic pathway for COPD
and other chronic respiratory diseases. These should
always be proposed, discussed and finalized together
with all interested parties (including patients and
their caregivers). To supervise that the official DTPs
are the standard to which all make reference. For
the adherence of GPs to the DTP, a ‘proactive
medicine’ approach should be incentivized.
2. A novel task of collecting clinical data, besides the
simple administrative ones, that would contribute to
represent the “in the field” real-world activity. This
data collection should also include audit initiatives.
Finally, patients, their caregivers, and associations,
have the responsibility for:
1. An optimum adherence to therapy and in general to
doctors’ prescriptions, after receiving the necessary
education about disease and learning how to verify
the progress. This duty to adherence includes
corrective actions in the case of manifest failure to
comply with the prescriptions or deviation from
them. For example, one should be rigorous about
suspending oxygen therapy if the patient, after being
offered smoking cessation treatment, continues
smoking.
2. A conscious and responsible use of health service
resources, consisting in hospital admission only
when strictly appropriate, with an increase in
scheduled control visits and a decrease in
unscheduled ones. In this respect, patient and
caregivers must be aware of the diagnostic-
therapeutic pathway, and should “called to account”
when their behavior diverges from the predicted
pattern, even if they are in non-emergency
conditions.
Sustainability
The final session of the Consensus Conference dealt
with sustainability based on these questions:
a. Does the multidisciplinary approach really give
support to sustainability?
The answer would be ‘yes’ if care pathways can be de-
signed that are supported by a network structure con-
sisting of the following nodes (depending on the
disease): hospital, community resources (GPs included),
and social services. In this context, the continuity and
appropriateness of care are the pillars on which to
organize the pathways. This requires that the programs
be patient-centered and include shared protocols based
on common organizational principles set out in
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the disease. The multidisciplinary approach could really
be a substantial support to sustainability if the technical
and professional path of the different care processes is
correctly defined, i.e. the protocols to which the different
professionals, each according to their own competence,
must necessarily refer to.
b. Does the pharmacist have a role in the
sustainability of the system?
The Assembly agreed that in a new organization aimed
at sustainability, the pharmacist can play a fundamental
role mainly as regards early diagnosis of COPD based on
filling in questionnaires, but also by counseling patients
to give up smoking and to maintain a correct life style,
training them to use inhalation devices now available
and to check periodically the appropriateness of their
use, and controlling the adherence to therapy.
It was also recognized as a priority to develop and
implement a valid program of specific respiratory educa-
tion for pharmacists, including an accreditation process,
as already performed in other countries like UK,
Australia, and Canada [12, 13], which allows them to
offer a high quality service that can meet the real needs
of patients. Such an educational resource could contrib-
ute to improve the respiratory health of the Italian popu-
lation through a greater adherence to therapy that could
lead to a significant reduction in direct and indirect
NHS costs. Therefore, the CC proposed that accredited
pharmacies display a specific identification mark
attached to the entrance of the pharmacy.
c. What is the effective role of pharmaceutical
industries and of pharmacotherapy for the
sustainability of the system?
Pharmaceutical industries could help in coping with
COPD and other chronic respiratory diseases by improving
quality of life and life expectancy through the development
of new drugs that are more effective, more user-friendly
and more sustainable than existing ones. It was pointed
out that, besides the role that State and Health Service can
play in terms of advocacy on chronic respiratory diseases,
pharmaceutical industries can too play a fundamental role
in education of people to health and of patients about their
disease. To this end, internet sites and network resources
can be used, clearly stating any conflicts of interest. There
is little doubt that educating patients on different issues
(e.g. improving their knowledge of risk factors, making
them aware of the importance and efficacy of prevention,
promoting educational campaigns, and stimulating and
improving education about therapy) will allow a better
control of the disease course and significantly reduceGP and respiratory specialist visits, admissions to the
emergency department, ordinary hospital admissions,
and the rate of lost working days or of inactivity.
Conclusions
To help the NHS to cope with chronic respiratory
diseases, the Research Center of the Italian Respiratory
Society organized in 2016 the 4th Consensus Confe-
rence on Respiratory Medicine. COPD was chosen as
the paradigm of chronic respiratory disease care. Spe-
cialists in different specialties (clinical and managerial)
discussed the main obstacles to an effective, safe and
sustainable respiratory care and proposed the solutions
to overcome them.
As for the education and training of health staff, the
university education in Italy of medical students on
respiratory medicine is currently sufficient. However,
respiratory pathophysiology, social aspects of chronic
conditions (like asthma and COPD) and practical
training need to be improved. This can be achieved by
forming an educational network linking the University
with excellent hospital units (for interventional and
emergency care) and forefront primary care structures
(for chronic conditions assisted via community and
population medicine).
To build a network aimed at providing integrated care
for respiratory patients, the role of an outpatient respira-
tory specialist, i.e. a chest physician working (full or part
time) outside the hospital, is capital. Such a physician
could create an intermediate level of care to help GPs
and the whole community in promoting primary
prevention and early diagnosis (particularly of COPD) as
well as managing chronic care post-hospitalization,
rehabilitation and finally in providing end-of-life care.
Although a network as described could help the NHS to
minimize hospitalizations, in Italy no standards of edu-
cation and no formal definitions of such a figure exist
(neither do they exist, actually, for specialized nurses
and physiotherapists able to work with the outpatient re-
spiratory specialist).
In shaping the new model of respiratory care a new
definition of responsibility of each stakeholder is
necessary. GPs (educated by chest physicians during
medical school about the fundamentals of respiratory
medicine) need to know the first level diagnostic tools
and how to manage them in prevention and treat-
ment. Putting together a group of GPs in which at
least one of them is specially interested in respiratory
medicine could help.
Respiratory specialists have the responsibility to be
educated and trained in second-level interventions.
Their practice should include not only theoretical and
practical issues about second-level respiratory medicine
but also the ability to carry out audits on both own
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Respiratory Society syllabus, as well as the ERS Hermes
program, could lead the way here.
A responsibility shared by GPs and respiratory special-
ists is to collaborate to build up diagnostic and thera-
peutic pathways of care as standards of care. Such
pathways and indeed all the actions needed for building
the new model of care require a multidisciplinary ap-
proach which is a responsibility of all stakeholders. A
model exists for COPD in Italy, built up by the Associa-
tions of Nationwide Health districts and Municipalities-
Federsanità-ANCI [10].
The NHS should have the responsibility to organize
the network, to pay for it and for the auditing of national
and regional DTP, to subsidize not only proactive
medicine but also data collection about different experi-
ences. NHS should also provide resources to the com-
munity for health education on living in good health and
to the patients and their caregivers tools for managing
disease in the best way.
While citizens have the responsibility to know and
practice the behaviors to prevent respiratory (and indeed
all) chronic conditions as well as the characteristics of
the early phases of respiratory diseases (to get confirm-
ation or disconfirmation of them through the appropri-
ate actions of secondary prevention), patients and
caregivers should be educated to self-management of
their disease with special attention to the proper use of
inhalation devices.
This last point emphasizes the role of pharmacists -
properly educated and trained - in the network.
Pharmacists can help in early diagnosis, in drug intake
monitoring (with special regard to drugs for comorbidi-
ties) and in monitoring adherence to treatment of
respiratory conditions as well as adverse effects. Finally,
pharmaceutical industries could help in coping with the
epidemic of chronic respiratory diseases by making avail-
able new drugs, with the aims of improving quality of
life and life expectancy. However, in our opinion, new
drugs must not only satisfy needs still not satisfied but
also do so in a sustainable way. In other words, new
drugs should be more effective, more user friendly, and
more sustainable than the existing ones [14]. In addition,
Pharma industries can collaborate in the management of
COPD and other chronic respiratory conditions by help-
ing in advocating on chronic respiratory diseases and in
educating the community to health and patients about
their disease.
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